Database Name Frequencies
CAFL Hypertension 2 10000 15 20 2112 304 324 528 6 7.83 727 787 880 9.19 95
XTRA Hypertension 3 10000 15 20 2112 304 3176 324 528 6 7.83 727 787 880 9.18 95
XTRA Infections 2 1500 1600 2112 2170 428 440 5000 600 625 650 700 760 776 787 832
CAFL Infections General Secondary 1500 1600 1865 2112 428 440 450 500 5000 600 625 650 660 666 690 700 760 776 832
XTRA Kidney Stimulation 100 1016 112 1134 1153 120 125 146 1500 152 1550 1600 1864 20 2112 2222 240 2400 250 2720 28 334 40 440 4412 442 465 524 582 600 625 64 644 651 668 676 712 72 728 732 751 784 800 854 880 93 96
CAFL Leukoderma Acquired 20 2112 440 444 600 650 727 787 880
XTRA Lymph Drain Circulation 1.5 10 10.36 1000 10000 146 148 15 15.05 15.33 1865 20 20.5 2112 3.6 3176 324 428 440 444 465 5000 522 528 6.3 66 660 676 690 727.5 743 787 8 880
CAFL Nerve Disorders and Neuropathy 10000 125 1550 1600 1800 20 2112 2170 2489 2720 440 600 625 650 660 72 727 787 802 880 95
XTRA Nerve Disorders and Neuropathy 10000 125 1550 1600 1800 20 2112 2170 2489 2720 3 3176 440 600 625 650 660 7.83 72 727 787 802 880 95
CAFL Parasites General 1 120 128 1550 1862 2112 422 4412 644 676 688 712 728 732 800
CAFL Parasites General Comprehensive 112 120 125 128 152 1550 1864 20 2112 240 2400 2720 334 422 4412 442 465 5000 524 64 644 651 688 712 72 728 732 800 854 880 96
CAFL Sexual Dysfunction Men 124 20 2008 2112 2127 465 600 625 650 666 690 72 727 73.95 787 802 880 9.39
CAFL Stroke Follow Up 10000 125 1800 1865 20 203 2112 2720 3 428 522 600 625 650 72 727 787 880 95
CAFL Vitiligo 20 2112 440 444 600 650 727 787 880